# Locally Delivered 1% Metformin Gel in Peri-implantitis

> **NCT03312582** · PHASE4 · COMPLETED · sponsor: **King Saud University** · enrollment: 46 (actual)

## Conditions studied

- Peri-Implantitis

## Interventions

- **DRUG:** 1% local metformin gel
- **PROCEDURE:** Placebo

## Key facts

- **NCT ID:** NCT03312582
- **Lead sponsor:** King Saud University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-03-15
- **Primary completion:** 2016-08-14
- **Final completion:** 2017-07-24
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2017-10-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03312582

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03312582, "Locally Delivered 1% Metformin Gel in Peri-implantitis". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03312582. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*